OMERS ADMINISTRATION Corp Buys 3,239 Shares of Waters Corporation $WAT

OMERS ADMINISTRATION Corp boosted its position in shares of Waters Corporation (NYSE:WAT) by 43.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,652 shares of the medical instruments supplier’s stock after acquiring an additional 3,239 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Waters were worth $3,172,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC grew its stake in shares of Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after purchasing an additional 673 shares during the period. Integrated Wealth Concepts LLC increased its position in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after purchasing an additional 30 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after purchasing an additional 6,976 shares during the period. Empowered Funds LLC lifted its stake in shares of Waters by 16.6% in the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in shares of Waters in the second quarter worth approximately $232,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Up 3.6%

Shares of WAT stock opened at $384.67 on Wednesday. The company has a market capitalization of $37.77 billion, a price-to-earnings ratio of 48.88, a PEG ratio of 2.24 and a beta of 1.20. Waters Corporation has a one year low of $275.05 and a one year high of $414.15. The company’s fifty day moving average price is $367.04 and its 200-day moving average price is $345.48. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same quarter in the prior year, the company posted $2.25 earnings per share. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Sell-side analysts expect that Waters Corporation will post 14.51 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on WAT shares. Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Monday, July 20th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $350.00 price target on shares of Waters in a research report on Thursday, May 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Friday, July 17th. UBS Group upped their price objective on Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Finally, Wolfe Research began coverage on Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price objective for the company. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $401.60.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.